| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |